Lıver NewsLatest News On Lıver Nevada jury hands $5.2 billion verdict against Vegas company in bottled water liver damage lawsuit10/24/2024 1:42 PM Dogecoin inspiration Kabosu dies, leaving legacy of $22.86 billion market cap5/24/2024 4:26 AM Biotech Company LyGenesis Doses First Human Patient with Donated Liver Cells4/2/2024 4:48 PM Which stocks might be disrupted next by Ozempic and other GLP-1 drugs10/12/2023 8:20 AM $228M awarded to some plaintiffs who sued Nevada-based bottled water company after liver illnesses10/5/2023 10:30 AM As weight loss drug stocks rallied on a landmark study, these stocks were over sold, analysts say8/11/2023 10:08 AM Liver King Expects Steroid Admission To Hurt Supplement Company Revenue12/10/2022 5:38 AM Why the FDA Wants to Stop Companies From Putting CBD in Everything10/5/2022 6:55 PM Akero Therapeutics soars more than 100% in early trading on early 'fatty liver' trial data - San Francisco Business Times9/13/2022 12:45 PM Turkey's shining liver transplant industry has humble origins12/24/2020 5:00 PM The 7 leading NASH biotechs with major 2020 catalysts - Business Insider2/25/2020 3:19 PM Intercept Pharmaceuticals CEO Mark Pruzanski on first NASH drug - Business Insider2/19/2020 1:46 PM The competition's heating up over a $35 billion market to treat NASH, a 'silent disease' millions are living with. But some of the early results don't look promising.2/12/2019 12:17 PM Viking Therapeutics stock rose 87% on results for its liver disease drug — and the company has more in store this fall9/18/2018 10:41 PM